Key facts
- This page summarizes Ulf Grawunder's Form 3 filing for Adagene Inc. (ADAG).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 17 Mar 2026, 08:56.
Ulf Grawunder - 17 Mar 2026 Form 3 Insider Report for Adagene Inc. (ADAG)
- Reporting relationship
- Director
- Issuer ticker
- ADAG
- Reported as of
- 17 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- Ulf Grawunder
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ulf Grawunder filed Form 3 for Adagene Inc. (ADAG) on 17 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002120696
Primary reporting owner
Grawunder Ulf
- Relationship
- Director
- Address
- RUETENENSTRASSE 41, BECKENRIED, SWITZERLAND
- Signature
- Ulf Grawunder
- Signature date
- 17 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ADAG
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 25,000
- Date
- 17 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ADAG
holding
Derivative
Nonqualified Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Mar 2026
- Ownership
- Direct
- Underlying class
- ADAG Ordinary Shares
- Underlying amount
- 40,000
- Exercise price
- $2.26
- Footnotes
- F1
ADAG
holding
Derivative
Nonqualified Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 17 Mar 2026
- Ownership
- Direct
- Underlying class
- ADAG Ordinary Shares
- Underlying amount
- 25,000
- Exercise price
- $2.03
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
40,000 of time-based stock option granted on 4/8/2024 under the Adagene Inc. 2021 Performance Incentive Plan and became exercisable with respect to 50% of the shares on each of the first second anniversaries of the date of the grant, accordingly, 20,000 shares subject to this option are vested and be exercisable.
Footnote F2
25,000 of time-based stock option granted on 2/5/2026 under the Adagene Inc. 2021 Performance Incentive Plan and became exercisable with respect to 25% of the shares on each of the first four anniversaries of the date of the grant